SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-21-050795
Filing Date
2021-04-15
Accepted
2021-04-15 16:31:06
Documents
7
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2113051d1_pre14a.htm PRE 14A 1198346
2 GRAPHIC tm2113051d1pre14aimg_001.jpg GRAPHIC 6921
3 GRAPHIC tm2113051d1pre14aimg_002.jpg GRAPHIC 3719
4 GRAPHIC tm2113051d1_pre14aimg003.jpg GRAPHIC 27062
5 GRAPHIC tm2113051d1_pre14aimg004.jpg GRAPHIC 13268
6 GRAPHIC tm2113051d1_pre14aimg001.jpg GRAPHIC 117048
7 GRAPHIC tm2113051d1_pre14aimg002.jpg GRAPHIC 140439
  Complete submission text file 0001104659-21-050795.txt   1625183
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35668 | Film No.: 21828840
SIC: 2834 Pharmaceutical Preparations